Logo image of 0UB.DE

UBS GROUP AG-REG (0UB.DE) Stock Fundamental Analysis

FRA:0UB - Deutsche Boerse Ag - CH0244767585 - Common Stock - Currency: EUR

33.96  +0.44 (+1.31%)

Fundamental Rating

4

0UB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 109 industry peers in the Capital Markets industry. 0UB has a bad profitability rating. Also its financial health evaluation is rather negative. 0UB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year 0UB was profitable.
In the past year 0UB had a positive cash flow from operations.
0UB had positive earnings in each of the past 5 years.
Each year in the past 5 years 0UB had a positive operating cash flow.
0UB.DE Yearly Net Income VS EBIT VS OCF VS FCF0UB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B -40B 60B 80B

1.2 Ratios

0UB's Return On Assets of 0.33% is in line compared to the rest of the industry. 0UB outperforms 42.20% of its industry peers.
0UB's Return On Equity of 5.76% is in line compared to the rest of the industry. 0UB outperforms 49.54% of its industry peers.
Industry RankSector Rank
ROA 0.33%
ROE 5.76%
ROIC N/A
ROA(3y)0.87%
ROA(5y)0.77%
ROE(3y)17.12%
ROE(5y)14.94%
ROIC(3y)N/A
ROIC(5y)N/A
0UB.DE Yearly ROA, ROE, ROIC0UB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With a Profit Margin value of 9.83%, 0UB perfoms like the industry average, outperforming 50.46% of the companies in the same industry.
0UB's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for 0UB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 9.83%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-20.78%
PM growth 5Y-6.71%
GM growth 3YN/A
GM growth 5YN/A
0UB.DE Yearly Profit, Operating, Gross Margins0UB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

2

2. Health

2.1 Basic Checks

The number of shares outstanding for 0UB has been reduced compared to 1 year ago.
0UB has less shares outstanding than it did 5 years ago.
The debt/assets ratio for 0UB has been reduced compared to a year ago.
0UB.DE Yearly Shares Outstanding0UB.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
0UB.DE Yearly Total Debt VS Total Assets0UB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T

2.2 Solvency

The Debt to FCF ratio of 0UB is 73.01, which is on the high side as it means it would take 0UB, 73.01 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 73.01, 0UB is in line with its industry, outperforming 59.63% of the companies in the same industry.
A Debt/Equity ratio of 4.15 is on the high side and indicates that 0UB has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 4.15, 0UB is doing worse than 62.39% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.15
Debt/FCF 73.01
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
0UB.DE Yearly LT Debt VS Equity VS FCF0UB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
0UB.DE Yearly Current Assets VS Current Liabilites0UB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 256.60% over the past year.
The Earnings Per Share has been growing slightly by 3.99% on average over the past years.
Looking at the last year, 0UB shows a quite strong growth in Revenue. The Revenue has grown by 19.00% in the last year.
0UB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.83% yearly.
EPS 1Y (TTM)256.6%
EPS 3Y-9.49%
EPS 5Y3.99%
EPS Q2Q%111.76%
Revenue 1Y (TTM)19%
Revenue growth 3Y11.11%
Revenue growth 5Y10.83%
Sales Q2Q%-3.74%

3.2 Future

The Earnings Per Share is expected to grow by 27.74% on average over the next years. This is a very strong growth
Based on estimates for the next years, 0UB will show a small growth in Revenue. The Revenue will grow by 1.67% on average per year.
EPS Next Y36.87%
EPS Next 2Y41.54%
EPS Next 3Y38.58%
EPS Next 5Y27.74%
Revenue Next Year-1.29%
Revenue Next 2Y0.73%
Revenue Next 3Y1.74%
Revenue Next 5Y1.67%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
0UB.DE Yearly Revenue VS Estimates0UB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B 40B 50B
0UB.DE Yearly EPS VS Estimates0UB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

0UB is valuated rather expensively with a Price/Earnings ratio of 20.96.
Compared to the rest of the industry, the Price/Earnings ratio of 0UB indicates a somewhat cheap valuation: 0UB is cheaper than 63.30% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.48, 0UB is valued a bit cheaper.
The Price/Forward Earnings ratio is 12.98, which indicates a correct valuation of 0UB.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 0UB indicates a somewhat cheap valuation: 0UB is cheaper than 75.23% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of 0UB to the average of the S&P500 Index (34.04), we can say 0UB is valued rather cheaply.
Industry RankSector Rank
PE 20.96
Fwd PE 12.98
0UB.DE Price Earnings VS Forward Price Earnings0UB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

71.56% of the companies in the same industry are more expensive than 0UB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 26.64
EV/EBITDA N/A
0UB.DE Per share data0UB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

0UB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as 0UB's earnings are expected to grow with 38.58% in the coming years.
PEG (NY)0.57
PEG (5Y)5.26
EPS Next 2Y41.54%
EPS Next 3Y38.58%

5

5. Dividend

5.1 Amount

0UB has a Yearly Dividend Yield of 2.41%. Purely for dividend investing, there may be better candidates out there.
0UB's Dividend Yield is a higher than the industry average which is at 5.77.
0UB's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.41%

5.2 History

The dividend of 0UB has a limited annual growth rate of 0.29%.
Dividend Growth(5Y)0.29%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

0UB pays out 44.91% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of 0UB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP44.91%
EPS Next 2Y41.54%
EPS Next 3Y38.58%
0UB.DE Yearly Income VS Free CF VS Dividend0UB.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B -40B 60B 80B
0UB.DE Dividend Payout.0UB.DE Dividend Payout, showing the Payout Ratio.0UB.DE Dividend Payout.PayoutRetained Earnings

UBS GROUP AG-REG

FRA:0UB (8/8/2025, 7:00:00 PM)

33.96

+0.44 (+1.31%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-29 2025-10-29
Inst Owners57.66%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap113.48B
Analysts76
Price Target32.12 (-5.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.41%
Yearly Dividend0.62
Dividend Growth(5Y)0.29%
DP44.91%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-14.88%
Min EPS beat(2)-25.26%
Max EPS beat(2)-4.5%
EPS beat(4)2
Avg EPS beat(4)1.25%
Min EPS beat(4)-25.26%
Max EPS beat(4)21.79%
EPS beat(8)3
Avg EPS beat(8)-50.44%
EPS beat(12)6
Avg EPS beat(12)-31.05%
EPS beat(16)10
Avg EPS beat(16)-16.52%
Revenue beat(2)0
Avg Revenue beat(2)-3.6%
Min Revenue beat(2)-5.19%
Max Revenue beat(2)-2.01%
Revenue beat(4)2
Avg Revenue beat(4)1.98%
Min Revenue beat(4)-5.19%
Max Revenue beat(4)8.05%
Revenue beat(8)6
Avg Revenue beat(8)5.48%
Revenue beat(12)10
Avg Revenue beat(12)4.57%
Revenue beat(16)14
Avg Revenue beat(16)6.46%
PT rev (1m)1.96%
PT rev (3m)N/A
EPS NQ rev (1m)14.51%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.53%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.82%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.96
Fwd PE 12.98
P/S 2.59
P/FCF 26.64
P/OCF 18.58
P/B 1.52
P/tB 1.65
EV/EBITDA N/A
EPS(TTM)1.62
EY4.77%
EPS(NY)2.62
Fwd EY7.7%
FCF(TTM)1.27
FCFY3.75%
OCF(TTM)1.83
OCFY5.38%
SpS13.13
BVpS22.41
TBVpS20.63
PEG (NY)0.57
PEG (5Y)5.26
Profitability
Industry RankSector Rank
ROA 0.33%
ROE 5.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 9.83%
GM N/A
FCFM 9.71%
ROA(3y)0.87%
ROA(5y)0.77%
ROE(3y)17.12%
ROE(5y)14.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-20.78%
PM growth 5Y-6.71%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 4.15
Debt/FCF 73.01
Debt/EBITDA N/A
Cap/Depr 57.2%
Cap/Sales 4.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 98.73%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)59.2%
Cap/Depr(5y)70.42%
Cap/Sales(3y)4.12%
Cap/Sales(5y)4.52%
Profit Quality(3y)167.93%
Profit Quality(5y)287.17%
High Growth Momentum
Growth
EPS 1Y (TTM)256.6%
EPS 3Y-9.49%
EPS 5Y3.99%
EPS Q2Q%111.76%
EPS Next Y36.87%
EPS Next 2Y41.54%
EPS Next 3Y38.58%
EPS Next 5Y27.74%
Revenue 1Y (TTM)19%
Revenue growth 3Y11.11%
Revenue growth 5Y10.83%
Sales Q2Q%-3.74%
Revenue Next Year-1.29%
Revenue Next 2Y0.73%
Revenue Next 3Y1.74%
Revenue Next 5Y1.67%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1.88%
EBIT Next 3Y23.72%
EBIT Next 5YN/A
FCF growth 1Y112.6%
FCF growth 3Y-64.98%
FCF growth 5Y-41.22%
OCF growth 1Y118.85%
OCF growth 3Y-52.92%
OCF growth 5Y-30.14%